At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
TMDX TransMedics Group, Inc.
Trading 03-16 10:42:29 EDT
126.08
+2.60
+2.10%
High127.54Low123.78Vol141.86K
Open125.01D1 Closing123.48Amplitude3.05%
Mkt Cap4.31BTradable Cap4.15BTotal Shares34.17M
T/O17.83MT/O Rate0.43%Tradable Shares32.95M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Kidney Expansion And Strong Outlook Might Change The Case For Investing In TransMedics Group (TMDX)
Simply Wall St.  ·  03-15 14:21
Kidney Expansion And Strong Outlook Might Change The Case For Investing In TransMedics Group (TMDX)
TransMedics Group Inc. Files Initial Beneficial Ownership Statement for Matthew S. Forsyth, Senior Vice President, General Counsel and Secretary
Reuters  ·  03-14 05:30
TransMedics Group Inc. Files Initial Beneficial Ownership Statement for Matthew S. Forsyth, Senior Vice President, General Counsel and Secretary
Transmedics Group Inc : Stifel Raises Target Price to $130 From $115
THOMSON REUTERS  ·  03-09
Transmedics Group Inc : Stifel Raises Target Price to $130 From $115
TransMedics Director David Weill Disposes of Common Shares
Reuters  ·  03-07
TransMedics Director David Weill Disposes of Common Shares
TransMedics CFO Gerardo Hernandez Disposes of Common Shares
Reuters  ·  03-05
TransMedics CFO Gerardo Hernandez Disposes of Common Shares
Piper Sandler Sticks to Their Buy Rating for TransMedics Group (TMDX)
TIPRANKS  ·  03-03
Piper Sandler Sticks to Their Buy Rating for TransMedics Group (TMDX)
Stock Track | TransMedics Soars 5.18% Intraday on Tax Benefit Boosting Q4 Earnings
Stock Track  ·  02-27
Stock Track | TransMedics Soars 5.18% Intraday on Tax Benefit Boosting Q4 Earnings
Transmedics Provides Information On Impact Of Release Of Valuation Allowance On Deferred Tax Assets On Previously Reported Quarterly Results
Reuters  ·  02-27
Transmedics Provides Information On Impact Of Release Of Valuation Allowance On Deferred Tax Assets On Previously Reported Quarterly Results
TransMedics Q4 net income hits USD 105.4 million on a FY effective tax rate of (77.0)%
Reuters  ·  02-27
TransMedics Q4 net income hits USD 105.4 million on a FY effective tax rate of (77.0)%
Press Release: TransMedics Provides Additional Information on the Impact of the Release of the Valuation Allowance on Deferred Tax Assets on Previously Reported Fourth Quarter Financial Results
Dow Jones  ·  02-27
Press Release: TransMedics Provides Additional Information on the Impact of the Release of the Valuation Allowance on Deferred Tax Assets on Previously Reported Fourth Quarter Financial Results
Stifel Nicolaus Remains a Hold on TransMedics Group (TMDX)
TIPRANKS  ·  02-25
Stifel Nicolaus Remains a Hold on TransMedics Group (TMDX)
Needham Raises Price Target on TransMedics Group to $174 From $166, Keeps Buy Rating
MT Newswires Live  ·  02-25
Needham Raises Price Target on TransMedics Group to $174 From $166, Keeps Buy Rating
TransMedics price target raised to $170 from $155 at Evercore ISI
TIPRANKS  ·  02-25
TransMedics price target raised to $170 from $155 at Evercore ISI
Oppenheimer Sticks to Their Buy Rating for TransMedics Group (TMDX)
TIPRANKS  ·  02-25
Oppenheimer Sticks to Their Buy Rating for TransMedics Group (TMDX)
Transmedics Group Inc : TD Cowen Raises Target Price to $190 From $170
THOMSON REUTERS  ·  02-25
Transmedics Group Inc : TD Cowen Raises Target Price to $190 From $170
TransMedics price target raised to $149 from $114 at JPMorgan
TIPRANKS  ·  02-25
TransMedics price target raised to $149 from $114 at JPMorgan
Stock Track | TransMedics Group Soars 6.56% in Pre-market on Strong Q4 Results, Upbeat Guidance and Analyst Upgrades
Stock Track  ·  02-25
Stock Track | TransMedics Group Soars 6.56% in Pre-market on Strong Q4 Results, Upbeat Guidance and Analyst Upgrades
Transmedics Group Inc : Needham Raises Target Price to $174 From $166
THOMSON REUTERS  ·  02-25
Transmedics Group Inc : Needham Raises Target Price to $174 From $166
TransMedics Group Is Maintained at Buy by Needham
Dow Jones  ·  02-25
TransMedics Group Is Maintained at Buy by Needham
Analysts Offer Insights on Healthcare Companies: TransMedics Group (TMDX) and Ceribell, Inc. (CBLL)
TIPRANKS  ·  02-25
Analysts Offer Insights on Healthcare Companies: TransMedics Group (TMDX) and Ceribell, Inc. (CBLL)

Introduction

Company Name.
TransMedics Group, Inc.
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage; and OCS Liver for the preservation of donor livers. The company was founded in 1998 and is headquartered in Andover, Massachusetts.
Issue price:
--